Covalon Technologies (OTCMKTS:CVALF – Get Free Report) released its quarterly earnings data on Thursday. The company reported $0.03 earnings per share for the quarter, beating the consensus estimate of $0.01 by $0.02, Zacks reports. Covalon Technologies had a return on equity of 3.31% and a net margin of 3.08%.
Covalon Technologies Stock Up 3.9%
OTCMKTS:CVALF opened at $1.49 on Thursday. The stock’s 50-day simple moving average is $1.37 and its 200 day simple moving average is $1.33. The firm has a market capitalization of $41.15 million, a PE ratio of 74.54 and a beta of 0.59. Covalon Technologies has a twelve month low of $1.16 and a twelve month high of $2.14.
Covalon Technologies Company Profile
Covalon Technologies Ltd. (OTCMKTS:CVALF) is a Canadian medical device and life sciences company specializing in advanced wound care and infection prevention solutions. Based in Toronto, Ontario, Covalon leverages proprietary photochemical bonding technology to create antimicrobial and anti-adhesion polymer coatings for a range of medical devices and wound dressings. The company’s core focus is on reducing surgical site infections and improving healing outcomes through innovative biomaterials.
The company’s product portfolio comprises hydrogel-based wound dressings and polymer-coated medical device components.
Further Reading
- Five stocks we like better than Covalon Technologies
- Investors Abandoned These 3 AI Stocks Too Early, Says Jeff Clark
- Freight Boom: The Hormuz Blockade Payday
- The Palantir Paradox—Record Numbers and a Stock That Won’t Cooperate
- TJX Companies Fires on All Cylinders With 9% Revenue Growth
Receive News & Ratings for Covalon Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covalon Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
